Scholars@Duke
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

First-in-human dose escalation of TEW-7197 monotherapy in subjects with advanced stage solid tumors

Clinical Trial Grant
Duke Scholars
Jeffrey Melson Clarke
Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

MedPacto, Inc

Start Date

August 1, 2014

End Date

March 31, 2020
 

Administered By

Duke Cancer Institute

Awarded By

MedPacto, Inc

Start Date

August 1, 2014

End Date

March 31, 2020